FDA Inspection 1022173 — Sosa Estani, M.D.
The FDA completed an inspection of Sosa Estani, M.D. on July 13, 2017 in Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Buenos Aires (Argentina)
Additional Details
Clinical Investigator (CI)